12 Sep 2020: NRA CET Daily Current Affairs [ENG]

NRA CET Daily Current Affairs

NRA-CET-Daily-Current-Affairs
NRA-CET-Daily-Current-Affairs

-> Jammu & Kashmir Free Health Insurance

-> UNICEF appointed Ayushmann Khurrana Celebrity Advocate

-> Pradhan Mantri Awaas Yojana- Grih Pravesh

Aryabhatta Research Institute of Observational Sciences (ARIES)


The Jammu & Kashmir government announced the health scheme in which the government will provide universal health insurance.

The scheme announced by Lt Governor Manoj Sinha will cover all the residents of the Union Territory.

The scheme which is implemented by Lt Governor in convergence with Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) will provide universal health insurance coverage to all the residents of Jammu & Kashmir.


UNICEF (United Nations International Children Education Fund) appointed Ayushmann Khurrana as its celebrity advocate for promoting and supporting its work around ending violence against children.

What is UNICEF

UNICEF, or the United Nations Children’s Fund is a United Nations agency responsible for providing humanitarian and developmental aid to children worldwide.

U.N. headquarters is based in New York City, USA


Prime Minister Narendra Modi inaugurated Pradhan Mantri Awaas Yojana. “Grih Pravesh” the programme was organized under Pradhan Mantri Awaas Yojana.

Shri Narendra Modi also interacted with the beneficiaries under PMAY-G in Madhya Pradesh.

What is Pradhan Mantri Awas Yojana

Pradhan Mantri Awas Yojana is an initiative by Government of India in which affordable housing will be provided to the urban poor with a target of building 20 million affordable houses by 31 March 2022.


Aryabhatta Research Institute of Observational Sciences (ARIES), an autonomous institute under the Department of Science & Technology (DST), Govt. of India.

Aryabhatta Research Institute of Observational Sciences is a leading research institute in Nainital, Uttarakhand which specializes in Astronomy, Astrophysics and Atmospheric Sciences.


Leave a Reply